The purpose of this study is to determine the effectiveness of percutaneous tibial nerve stimulation (PTNS) therapy with the Urgent® PC Neuromodulation System (Uroplasty, Inc., Minnetonka, MN, USA) for the treatment of fecal incontinence (FI).
Pilot Study
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
The Urgent PC Neuromodulation System (Uroplasty, Inc., Minnetonka, MN, USA), device, is an easily administered neuromodulation system designed to deliver retrograde access to the sacral nerve through percutaneous electrical stimulation of the tibial nerve. This method of treatment is referred to as percutaneous tibial nerve stimulation (PTNS).
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
UCSF Center for Colorectal Surgery
San Francisco, California, United States
Minnesota Colon and Rectal Surgery Associates, Ltd.
Minneapolis, Minnesota, United States
The Lindner Center for Research and Education at The Christ Hospital
Cincinnati, Ohio, United States
Effectiveness
To assess the effectiveness of PTNS by measuring the proportion of patients with ≥50% decrease in the number of fecal incontinence episodes per week based on the results of the 14-day bowel diary at 18 weeks compared to baseline
Time frame: 18 weeks
Safety
To characterize adverse events experienced throughout the study
Time frame: 18 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Colorectal Surgical Asociates
Houston, Texas, United States
Providence Health and Services
Spokane, Washington, United States